openPR Logo
Press release

Global Infliximab and Biosimilar Market Analysis during 2022-2028

03-24-2022 12:04 PM CET | Health & Medicine

Press release from: Orion Market Reseach

The global infliximab and biosimilar market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The infliximab is a monoclonal anti-tumor necrosis antibody used to treat certain types of arthritis (rheumatoid arthritis, psoriatic arthritis), certain bowel diseases (Crohn's disease and ulcerative colitis), and serious skin disease (chronic plaque psoriasis). Biosimilar is a medicine that is close in structure and function to a biological drug. The rise in the prevalence of arthritis across the globe is anticipated to drive the growth of the global infliximab and biosimilar market. For instance, according to the data published by the Center for Disease Control and Prevention (CDC) in 2021, the prevalence of doctor-diagnosed arthritis is anticipated to increase in the forthcoming decades. Further, by 2040, approximately 78.4 million adults aged 18 years and older are anticipated to develop doctor-diagnosed arthritis, out of which two-thirds are expected to be women. Further, by 2040, approximately 36.4 million adults are anticipated to report arthritis-attributable activity limitations.
 
According to the data published by Crohn's & Colitis Foundation of America (CCFA) in 2019, approximately 1.6 million Americans suffer from Inflammatory Bowel Disease (IBD) out of which 80000 children are expected to have IBD. Further, 70,000 new cases of IBD are diagnosed in the US annually. Moreover, Crohn's disease and ulcerative diseases are chronic illnesses and changes are likely to occur over time. For instance, as per the same source, 50.0% of the patients suffering from Crohn's disease will have mild disease over the next five years. 45.0% of those will remain relapse-free over the next year and 35.0% will have one or two relapses. Thus, for a Crohn's disease patient in remission, the relapses rate at one, two, five, and ten years are estimated at 20.0%, 40.0%, 67.0%, and 76.0% respectively. Thus, the rise in the prevalence of IBD across the globe is anticipated to drive the growth of the infliximab and biosimilar market globally.
 
Looking towards the demand for infliximab and biosimilar, key market players are adopting various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in February 2022, Amneal Pharmaceuticals and Kashiv Biosciences have received the USFDA approval for Releuko(filgrastim-ayow) biosimilar. The Releuko biosimilar is anticipated to launch in the third quarter of 2022 as a treatment option for neutropenia, a low blood cell condition experienced by chemotherapy patients.
 
Additionally, in June 2021, Celltrion Healthcare Canada Ltd. announced the launch of Remsima Sc (CT-P13 SC) with a subcutaneous formulation, for the treatment of adult patients with rheumatoid arthritis (RA). Moreover, in January 2021, Health Canada has granted a notice for compliance (NOC) for Remsima SC in Canada for the treatment of rheumatoid arthritis in adults. Thus , such product launches coupled with approvals are anticipated to drive the growth of the market during the forecast period.

(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Infliximab and Biosimilar Market at https://orionmarketreports.com/request-sample/?id=92680&submit=Request+Sample%0D%0A

Market Coverage
 
The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Route of Administration
By Product
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Merck & Co., Pfizer Inc., Sandoz International GmbH, and Celltrion Healthcare co, Ltd. among others

A full report is available at: https://orionmarketreports.com/global-infliximab-and-biosimilar-market/92680/
 

Global Infliximab and biosimilar market Report by Segment
 By Route of Administration
Subcutaneous
Intravenous
Parenteral
Molecules Type

By Product
Mono
combination

Key questions addressed by the report
What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Infliximab and Biosimilar Market Analysis during 2022-2028 here

News-ID: 2585944 • Views: 213

More Releases from Orion Market Reseach

Hybrid PV Inverter Market to Witness Robust Expansion by 2028
In order to form Hybrid PV Inverter Market research report, market analysts do comprehensive market study and points out exact causes of sales decrease as well as reasons behind it. It further helps to decide on the exact problem source and provides ways to deal with it. For making business financially stable, decision making has great significance. In this regard, referring Hybrid PV Inverter Market study report is important as
Aquarium Filters Market Top Leading Players with Strategies and Forecast 2028
Aquarium Filters Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Aquarium Filters market with a focus on the market. Key Players Aqua Design Amano (JP) EHEIM (DE) Marukan (JP) Den Marketing (UK) Clear-Seal (UK) Waterlife (UK)   By Type Self-Cleaning Filter Automatic Filter Stainless Steel Brush Filter   By Application Store Aquarium Household Other  Scope of the Report The research study analyses the Aquarium Filters Market from 360-degree analysis of the market thoroughly delivering insights into the market for better
Aquaculture Automatic Feeding Machines Market Top Leading Players with Strategie …
Aquaculture Automatic Feeding Machines Market Size, Share & Trends Analysis is a professional and in-depth study on the current state of the global Aquaculture Automatic Feeding Machines market with a focus on the market. The report provides key statistics on market of Aquaculture Automatic Feeding Machines. It is a valuable source of guidance and direction for companies and individuals interested in Aquaculture Automatic Feeding Machines industry. Key Players Aquaculture Equipment Ltd Pioneer A.E.
Global Anastrozole Tablets Market Top Leading Players with Strategies and Foreca …
The global anastrozole tablets market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rising incidence of breast cancer among the population across the globe is primary factor contributing towards the growth of the market. Anastrozole tablets are primarly used to used for hormone receptor-positive breast cancer. It is also been used to prevent breast cancer in women which are at high risk of menopause. According to the

All 5 Releases


More Releases for Crohn

Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the
Crohns Disease Drug Market 2020 Recent Industry Developments and Growth Strateg …
ReportsnReports provides in depth study of "Crohns Disease Drug Market" using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organisation. The Crohns Disease Drug Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organisation such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organisation. The global
Crohns Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Order a Copy of
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025. This study answers several questions for stakeholders, primarily which market segments
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Johnson & Johnson Pfizer Sanofi Merck GSK AbbVie Takeda Ferring UCB Boehringer Ingelheim Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Crohn Disease can be split into Small Intestine and Ileocephalitis Colon Disease Market segment